Solitary Plasmacytoma — Trials

Solitary Plasmacytoma — Trials · CancerIndex

Clinical trials

Registered studies

3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Peking Union Medical College Hospital
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06863584	SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial	recruiting	Phase 2	41	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Mar 7, 2025	clinicaltrials
NCT05248633	Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma	recruiting	Phase 2	220	Peking Union Medical College HospitalOTHER	1	Jun 5, 2024	clinicaltrials